{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:37:31Z","timestamp":1789439851922,"version":"build-2803163510"},"reference-count":56,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2025,8,31]]},"DOI":"10.5582\/irdr.2025.01046","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T22:07:25Z","timestamp":1754086045000},"page":"192-202","source":"Crossref","is-referenced-by-count":3,"title":["Towards an Asian paradigm of inflammatory bowel disease management: A comparative review of China and Japan"],"prefix":"10.5582","volume":"14","author":[{"given":"Qi","family":"Sun","sequence":"first","affiliation":[{"name":"Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China."},{"name":"Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Song","sequence":"additional","affiliation":[{"name":"Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwen","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ma T, Wan M, Liu G, Zuo X, Yang X, Yang X. Temporal trends of inflammatory bowel disease burden in China from 1990 to 2030 with comparisons to Japan, South Korea, the European Union, the United States of America, and the world. Clinical Epidemiology. 2023; 15:583-599.","DOI":"10.2147\/CLEP.S402718"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023; 402:571-584.","DOI":"10.1016\/S0140-6736(23)00966-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dolinger M, Torres J, Vermeire S. Crohn&apos;s disease. Lancet. 2024; 403:1177-1191.","DOI":"10.1016\/S0140-6736(23)02586-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kaplan GG. The global burden of IBD: From 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015; 12:720-727.","DOI":"10.1038\/nrgastro.2015.150"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hracs L, Windsor JW, Gorospe J, <i>et al.<\/i> Global evolution of inflammatory bowel disease across epidemiologic stages. Nature. 2025; 642:458-466.","DOI":"10.1038\/s41586-025-08940-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Murakami Y, Nishiwaki Y, Oba MS, Asakura K, Ohfuji S, Fukushima W, Suzuki Y, Nakamura Y. Estimated prevalence of ulcerative colitis and Crohn&apos;s disease in Japan in 2014: An analysis of a nationwide survey. J Gastroenterol. 2019; 54:1070-1077.","DOI":"10.1007\/s00535-019-01603-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yang H, Zhou R, Bai X, Guo M, Ruan G, Wang L, Qian J. Trend and geographic variation in incidence and prevalence of inflammatory bowel disease in regions across China: A nationwide employee study between 2013 and 2016. Front Med (Lausanne). 2022; 9:900251.","DOI":"10.3389\/fmed.2022.900251"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mahlich J, Matsuoka K, Sruamsiri R. Biologic treatment of Japanese patients with inflammatory bowel disease. BMC Gastroenterol. 2018; 18:160.","DOI":"10.1186\/s12876-018-0892-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kanatani Y, Tomita N, Sato Y, Eto A, Omoe H, Mizushima H. National registry of designated intractable diseases in Japan: Present status and future prospects. Neurol Med Chir (Tokyo). 2017; 57:1-7.","DOI":"10.2176\/nmc.st.2016-0135"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Du X, Luo X, Guo Q, Jiang X, Su Z, Zhou W, Wang Z, Li J, Yang Y, Zhang Y. Assessment of clinical benefit, cost and uptake of biosimilars versus reference biologics in immune-mediated inflammatory diseases in China. Front Public Health. 2024; 12:1476213.","DOI":"10.3389\/fpubh.2024.1476213"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takenaka K, Ohtsuka K, Fujii T, Negi M, Suzuki K, Shimizu H, Oshima S, Akiyama S, Motobayashi M, Nagahori M, Saito E, Matsuoka K, Watanabe M. Development and validation of a deep neural network for accurate evaluation of endoscopic images from patients with ulcerative colitis. Gastroenterol. 2020; 158:2150-2157.","DOI":"10.1053\/j.gastro.2020.02.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Takenaka K, Ohtsuka K, Fujii T, Oshima S, Okamoto R, Watanabe M. Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images. Gastroenterol. 2021; 160:2175-2177.e3.","DOI":"10.1053\/j.gastro.2021.01.210"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association; Inflammatory Bowel Disease Quality Control Center of China. 2023 Chinese national clinical practice guideline on diagnosis and management of ulcerative colitis. Chin Med J (Engl). 2024; 137:1642-1646.","DOI":"10.1097\/CM9.0000000000003221"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association; Inflammatory Bowel Disease Quality Control Center of China. 2023 Chinese national clinical practice guideline on diagnosis and management of Crohn&apos;s disease. Chin Med J (Engl). 2024; 137:1647-1650.","DOI":"10.1097\/CM9.0000000000003222"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yu T, Li W, Liu Y, Jin C, Wang Z, Cao H. Application of Internet hospitals in the disease management of patients with ulcerative colitis: Retrospective study. J Med Internet Res. 2025; 27:e60019.","DOI":"10.2196\/60019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hiwatashi N. Enteral nutrition for Crohn&apos;s disease in Japan. Dis Colon Rectum. 1997; 40:S48-S53.","DOI":"10.1007\/BF02062020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ishige T, Tomomasa T, Tajiri H, Yoden A, Disease JSGfPCs. Japanese physicians&apos; attitudes towards enteral nutrition treatment for pediatric patients with Crohn&apos;s disease: A questionnaire survey. Intest Res. 2017; 15:345-351.","DOI":"10.5217\/ir.2017.15.3.345"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Hiraoka S, Huang Z, Qin F, Arokianathan FMN, Dav\u00e9 K, Shah S, Kim H. Health-related quality of life, work productivity, and persisting challenges in treated ulcerative colitis patients: A Japanese national health and wellness survey. Intest Res. 2025. doi: 10.5217\/ir.2024.00104. Epub ahead of print.","DOI":"10.5217\/ir.2024.00104"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhang Y, Chung H, Fang QW, Xu YR, Zhang YJ, Nakajo K, Wong IC, Leung WK, Qiu H, Li X. Current and forecasted 10-year prevalence and incidence of inflammatory bowel disease in Hong Kong, Japan, and the United States. World J Gastroenterol. 2025; 31:105472.","DOI":"10.3748\/wjg.v31.i18.105472"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Okabayashi S, Kobayashi T, Hibi T. Inflammatory bowel disease in Japan-Is it similar to or different from Westerns? J Anus Rectum Colon. 2020; 4:1-13.","DOI":"10.23922\/jarc.2019-003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yu Z, Ruan G, Bai X, Sun Y, Yang H, Qian J. Growing burden of inflammatory bowel disease in China: Findings from the Global Burden of Disease study 2021 and predictions to 2035. Chin Med J (Engl). 2024; 137:2851-2859.","DOI":"10.1097\/CM9.0000000000003345"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shah SC, Khalili H, Chen C-Y, Ahn HS, Ng SC, Burisch J, Colombel JF. Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region. Aliment Pharmacol Ther. 2019; 49:904-911.","DOI":"10.1111\/apt.15178"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Park SH. Update on the epidemiology of inflammatory bowel disease in Asia: Where are we now? Intest Res. 2022; 20:159-164.","DOI":"10.5217\/ir.2021.00115"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zhao J, Ng SC, Lei Y, <i>et al.<\/i> First prospective, population-based inflammatory bowel disease incidence study in mainland of China: The emergence of &quot;Western&quot; disease. Inflamm Bowel Dis. 2013; 19:1839-1845.","DOI":"10.1097\/MIB.0b013e31828a6551"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ng SC, Kaplan GG, Tang W, <i>et al.<\/i> Population density and risk of inflammatory bowel disease: A prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019; 114:107-115.","DOI":"10.1038\/s41395-018-0233-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Liang Q, Qu B, Li C, Hu Y, Yang C, Yang T, Di Y, Li H. Clinical characteristics and North-South differences of inflammatory bowel disease in China: A cross-sectional study and meta-analysis. Frigid Zone Medicine. 2024; 4:23-30.","DOI":"10.2478\/fzm-2024-0003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Aniwan S, Santiago P, Loftus EV, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United European Gastroenterol J. 2022; 10:1063-1076.","DOI":"10.1002\/ueg2.12350"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shi H, Levy AN, Trivedi HD, Chan FK, Ng SC, Ananthakrishnan AN. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: A systematic review and meta-analysis of population-based studies. Clin Gastroenterol Hepatol. 2018; 16:190-197.e11.","DOI":"10.1016\/j.cgh.2017.05.047"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, N\u00fa\u00f1ez G, Kishi Y, Koike Y, Shimosegawa T, Shimoyama T, Hibi T. Lack of common NOD2 variants in Japanese patients with Crohn&apos;s disease. Gastroenterol. 2002; 123:86-91.","DOI":"10.1053\/gast.2002.34155"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021; 18:56-66.","DOI":"10.1038\/s41575-020-00360-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017; 390:2769-2778.","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. M&apos;Koma AE. Inflammatory bowel disease: An expanding global health problem. Clin Med Insights Gastroenterol. 2013; 6:33-47.","DOI":"10.4137\/CGast.S12731"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Zeng Z, Zhu Z, Yang Y, <i>et al.<\/i> Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: A prospective population-based study. J Gastroenterol Hepatol. 2013; 28:1148-1153.","DOI":"10.1111\/jgh.12164"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Liu X, Yang Q, Diao N, Tang J, Huang Z, Gao X, Chao K. Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: A retrospective cohort study. Intest Res. 2024; 22:357-368.","DOI":"10.5217\/ir.2023.00106"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Song EM, Na S-Y, Hong SN, Ng SC, Hisamatsu T, Ye BD. Treatment of inflammatory bowel disease\u2013Asian perspectives: The results of a multinational web-based survey in the 8th Asian Organization for Crohn&apos;s and Colitis meeting. Intest Res. 2023; 21:339-352.","DOI":"10.5217\/ir.2022.00135"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Taida T, Ohta Y, Kato J, <i>et al.<\/i> Treatment strategy changes for inflammatory bowel diseases in biologic era: Results from a multicenter cohort in Japan, far east 1000. Sci Rep. 2023; 13:13555.","DOI":"10.1038\/s41598-023-40624-5"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Miyoshi J, Yoon A, Matsuura M, Hisamatsu T. Real-world use of biologics during the first year of treatment for newly diagnosed Crohn&apos;s disease in Japan: A claims analysis from 2010 to 2021. Intest Res. 2025. doi: 10.5217\/ir.2024.00082. Epub ahead of print.","DOI":"10.5217\/ir.2024.00082"},{"key":"38","unstructured":"38. Liu LY, Wei LJ, Zhang MX, Tang YY, Zhang CM. Investigation and analysis of disease cognition among parents of children with inflammatory bowel disease. Internatl Med Health Guidance News. 2023; 29:3497-3500. (in Chinese)"},{"key":"39","unstructured":"39. Committee of Inflammatory Bowel Disease, Chinese Society of Gastroenterology. Chinese consensus on therapeutic drug monitoring in inflammatory bowel disease. Zhonghua Xiaohua Zazhi (Chinese Journal of Digestion). 2018; 38:721-727. (in Chinese)"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Liu H, Li J, Yuan J, Huang J, Xu Y. Fecal microbiota transplantation as a therapy for treating ulcerative colitis: An overview of systematic reviews. BMC Microbiol. 2023; 23:371.","DOI":"10.1186\/s12866-023-03107-1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn&apos;s disease. World J Gastroenterol. 2013; 19:7213-7216.","DOI":"10.3748\/wjg.v19.i41.7213"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, Xu H, Xiang J, He Z, Zhang T, Nie Y, Wu K, Fan D, Ji G, Zhang F. Step-up fecal microbiota transplantation strategy: A pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015; 13:298.","DOI":"10.1186\/s12967-015-0646-2"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Arora U, Kedia S, Ahuja V. The practice of fecal microbiota transplantation in inflammatory bowel disease. Intest Res. 2023; 22:44-64.","DOI":"10.5217\/ir.2023.00085"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Mizuno S, Nanki K, Matsuoka K, Saigusa K, Ono K, Arai M, Sugimoto S, Kiyohara H, Nakashima M, Takeshita K, Naganuma M, Suda W, Hattori M, Kanai T. Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients. Intest Res. 2017; 15:68-74.","DOI":"10.5217\/ir.2017.15.1.68"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Kanai T, Mikami Y, Hayashi A. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease. J Gastroenterol. 2015; 50:928-939.","DOI":"10.1007\/s00535-015-1084-x"},{"key":"46","unstructured":"46. Prajapati HJ, Patel MP, Athalye MN, Bharadia PD. Role of probiotics in ulcerative colitis. Sys Rev Pharm. 2022; 13:334-341."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Mizuno H, Katashima M, Sakagami K, Fujimoto Y, Murauchi C, Seto N. Factors of self-care agency in patients with inflammatory bowel disease in Japan. Inflamm Intest Dis. 2024; 9:103-114.","DOI":"10.1159\/000538007"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Peng L, Hu S, Yu Q, Chen Y. Challenging the surge of inflammatory bowel disease: The role of the China Crohn&apos;s and Colitis Foundation in the healthcare landscape of inflammatory bowel disease. Inflamm Bowel Dis. 2022; 28:S9-S15.","DOI":"10.1093\/ibd\/izab344"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Thi Thanh Tran H, Saito S, Noto S, Suzuki K. Quality of life and eligibility for specific financial assistance for medical expenses: A cross-sectional web-based survey among patients with inflammatory bowel disease in Japan. Gastrointest Disorders. 2020; 2:123-133.","DOI":"10.3390\/gidisord2020012"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Yu L, Bo-Kun Z, Qing-Sheng M, Mei J, Min L. Effects of adalimumab entering national reimbursement on medical costs for patients with psoriasis: A 4-year single-center retrospective study in China. Interntal J Dermatol Venereol. 2024; 7:84-88.","DOI":"10.1097\/JD9.0000000000000310"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Sajadinejad MS, Asgari K, Molavi H, Kalantari M, Adibi P. Psychological issues in inflammatory bowel disease: An overview. Gastroenterol Res Pract. 2012; 2012:106502.","DOI":"10.1155\/2012\/106502"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Graffigna G, Bosio C, Pagnini F, Volpato E, Previtali E, Leone S, D&apos;Amico F, Armuzzi A, Danese S. Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: An Italian consensus statement. BMC Psychol. 2021; 9:186.","DOI":"10.1186\/s40359-021-00692-6"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Fu H, Kaminga AC, Peng Y, Feng T, Wang T, Wu X, Yang T. Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: The mediating role of psychological symptoms. BMC Gastroenterol. 2020; 20:11.","DOI":"10.1186\/s12876-020-1166-y"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Volpato E, Bosio C, Previtali E, Leone S, Armuzzi A, Pagnini F, Graffigna G. The evolution of IBD perceived engagement and care needs across the life-cycle: A scoping review. BMC Gastroenterol. 2021; 21:293.","DOI":"10.1186\/s12876-021-01850-1"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Zhao J, Han H, Zhong B, Xie W, Chen Y, Zhi M. Health information on social media helps mitigate Crohn&apos;s disease symptoms and improves patients&apos; clinical course.. Comput Human Behav. 2021; 115:106588.","DOI":"10.1016\/j.chb.2020.106588"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Yu Q, Xu L, Li L, <i>et al<\/i>. Internet and WeChat used by patients with Crohn&apos;s disease in China: A multi-center questionnaire survey. BMC Gastroenterol. 2019; 19:97.","DOI":"10.1186\/s12876-019-1011-3"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/14\/3\/14_2025.01046\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:29:29Z","timestamp":1757132969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/14\/3\/14_2025.01046\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2025.01046","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"article-number":"2025.01046"}}